Skip to main content
OpenTrials
Completed

NCT Number: NCT07487974

Active Oxygen and Negative Ion Sanitary Pads for Episiotomy Pain, Healing, and Postpartum Symptoms

This study is to assess the impact of sanitary pads infused with active oxygen and negative ions on episiotomy pain, wound healing, and postpartum physical symptoms in primiparous women. Participants will be randomly allocated to either the intervention group, utilizing active oxygen and negative ion pads, or the control group, employing normal postpartum pads. The research will assess pain intensity, recovery advancement, and physical manifestations during the initial postpartum phase. The objective is to ascertain if the intervention offers supplementary advantages relative to usual care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Eğitim ve Araştırma Hastanesi

Karaman, Turkey (Türkiye)

About this study

Episiotomy is a surgical incision made during vaginal birth to enlarge the vaginal opening and support delivery. Although it can help prevent complications during childbirth, many women experience pain, discomfort, difficulty sitting, and delayed wound healing after the procedure. In the postpartum period, appropriate hygiene and wound care are essential to reduce discomfort, prevent infection, and support the healing of the perineal area. The tissues around the vulva and vagina become more sensitive due to increased moisture and hormonal changes, making the choice of hygiene products particularly important.

Sanitary pads containing active oxygen and negative ions have recently been introduced as a new type of hygiene product. These components are believed to improve comfort, support wound healing, and reduce irritation. Although their clinical effects in the postpartum period have not yet been extensively studied, their potential benefits make them a promising option for women recovering from episiotomy.

This study aims to examine whether sanitary pads with active oxygen and negative ions can reduce episiotomy pain, support wound healing, and decrease postpartum physical symptoms in primiparous women. Participants will be randomly assigned to either the intervention group using these special pads or the control group using standard postpartum pads. The findings may contribute to determining whether these products offer additional advantages in the early postpartum recovery process.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women aged 18 years or older
  • At least primary school education
  • Gestational age between 37 and 42 weeks
  • Single, live, vaginal birth
  • Mediolateral episiotomy performed
  • Hemoglobin level > 11 mg/dL
  • Voluntary participation and ability to provide informed consent

Exclusion criteria

  • History of high-risk pregnancy
  • History of high-risk or complicated labor
  • Use of operative vaginal delivery methods (forceps, vacuum, etc.)
  • Presence of additional perineal lacerations, including 3rd-degree tears or anal sphincter injury
  • Cephalopelvic disproportion
  • Postpartum hemorrhage
  • Newborn requiring NICU care
  • Diagnosis of vaginal fungal infection or sexually transmitted infections (e.g., herpes simplex, HPV)

Treatment and study plan

Active Oxygen and Negative Ion Sanitary Pad

Other

Participants in the intervention group will use sanitary pads containing active oxygen and negative ions during the early postpartum period following episiotomy. The product is applied as a hygiene pad and is not classified as a drug or medical device. Routine postpartum care will be provided to all participants.

Standard Postpartum Sanitary Pad

Other

Participants in the control group will use standard postpartum sanitary pads following episiotomy. Routine postpartum care will be provided to all participants. The control product does not contain active oxygen or negative ions.

Primary outcomes

  1. Episiotomy Pain Score

    Time frame: Measurements will be conducted at: • 24 hours postpartum • 3rd day postpartum • 7th day postpartum

    Episiotomy-related pain will be assessed using a 10-point Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst possible pain.

  2. Episiotomy Wound Healing Score

    Time frame: Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum

    Wound healing will be evaluated using the REEDA Scale (Redness, Edema, Ecchymosis, Discharge, Approximation).

    Each item is scored from 0 to 3, with a total score ranging from 0 to 15. Higher scores indicate poorer wound healing (greater tissue trauma).

  3. Postpartum Physical Symptom Severity

    Time frame: Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum

    Postpartum physical symptom severity will be measured using the Postpartum Physical Symptom Severity Scale.

    The scale consists of 18 items, each rated on a 4-point Likert scale (0 = none, 1 = mild, 2 = moderate, 3 = severe), with total scores ranging from 0 to 54.

    Higher scores indicate greater severity of postpartum physical symptoms.

Sponsors and collaborators

Lead sponsor

KTO Karatay University

Other

Registry information

Official study title

Effects of Active Oxygen and Negative Ion Sanitary Pads on Episiotomy Pain, Healing, and Postpartum Physical Symptom Severity in Primiparous Women: A Randomized Controlled Trial

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Mar 23, 2026
Registry last updated
May 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.